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Vascular and nervous systems, two major networks
in mammalian bodies, show a high degree of ana-
tomical parallelism and functional crosstalk. During
development, neurons guide and attract blood ves-
sels, and consequently this parallelism is estab-
lished. Here, we identified a noncanonical neurovas-
cular interaction in eye development and disease.
VEGFR2, a critical endothelial receptor for VEGF,
was more abundantly expressed in retinal neurons
than in endothelial cells, including endothelial tip
cells. Genetic deletion of VEGFR2 in neurons
caused misdirected angiogenesis toward neurons,
resulting in abnormally increased vascular density
around neurons. Further genetic experiments re-
vealed that this misdirected angiogenesis was
attributable to an excessive amount of VEGF protein
around neurons caused by insufficient engulfment
of VEGF by VEGFR2-deficient neurons. Moreover,
absence of neuronal VEGFR2 caused misdirected
regenerative angiogenesis in ischemic retinopathy.
Thus, this study revealed neurovascular crosstalk
and unprecedented cellular regulation of VEGF:
retinal neurons titrate VEGF to limit neuronal
vascularization.584 Cell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc.INTRODUCTION
The vascular and nervous systems are two major networks
that run throughout the bodies of mammalians. They are highly
interactive in both physiological (Mukouyama et al., 2002) and
pathological (Lambrechts et al., 2003) settings and share some
critical guidance molecules (Lu et al., 2004; Adams and Eich-
mann, 2010; Erskine et al., 2011).
The retina, a part of the central nervous system, is postnatally
vascularized basically through sprouting angiogenesis (Dorrell
et al., 2002; Gariano and Gardner, 2005; Pitulescu et al., 2010).
During the first week of life in rodents, the retinal vasculature
grows along the ganglion cell layer (GCL), the innermost surface
of the retina forming the superficial vascular plexus, but does not
grow into the area where neurons and neuronal progenitors exist
(i.e., neuroretina). Afterward, the deep and intermediate vascular
plexuses are serially formed, and three vascular plexuses are
completed 3 weeks after birth (Milde et al., 2013; Gerhardt
et al., 2003; Gariano and Gardner, 2005). Within the GCL, astro-
cytes form a mesh before the vascular growth and guide angio-
genic growth by providing vascular endothelial growth factor
(VEGF) and extracellular matrices (Dorrell et al., 2002; Gerhardt
et al., 2003; Ruhrberg et al., 2002; Stenzel et al., 2011). There-
fore, it is conceivable that the astrocytic template holds the
vasculature in the GCL and keeps it from growing into the neuro-
retina. However, pharmacological or genetic ablation of astro-
cytes does not cause abnormal growth of blood vessels into
the neuroretina (Gerhardt et al., 2003; Fruttiger et al., 1996),
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Figure 1. VEGFR2 Is More Highly Expressed in Retinal Neurons Than in Endothelial Cells
(A–M) Immunostaining of whole-mount tissues or sections from Vegfr2-BAC-EGFP+Vegfr1-BAC-DsRed+ mice. In retina, GFP is more abundant in neurons
(closed arrowheads) than in endothelial cells (open arrowheads). In ear skin, trachea, fat, brain, and bonemarrow, GFP and RFP are restricted to endothelial cells,
except for GFP expression in Clara cells of lung bronchioles (Br).
(N–Y) Immunohistochemistry in retinal sections from Vegfr2-BAC-EGFP+Vegfr1-BAC-DsRed+mice (N–U) and X-gal staining in the retina ofVegfr2+/lacZmice (V–Y)
at various developmental stages. VEGFR2 is strongly expressed in neuroretina during the first postnatal week.
(Z and AA) Whole-mount staining for P2 retinas. Scale bars represent 500 mm (A–D and N–Q) and 50 mm (E–M and R–AA).
See also Figure S1.suggesting the existence of some unknown cellular mechanism
for neurovascular interaction. Here, we identified a noncanonical
neurovascular interaction in eye development and disease; neu-
rons titrate VEGF to determine the direction of angiogenesis,
ensuring an appropriate level of vascular supply.
RESULTS
VEGFR2 Is More Abundant in Retinal Neurons Than
in Endothelial Cells
Several reports have suggested that VEGFR2 is expressed in
some neuronal cells in the retina (Yang and Cepko, 1996;
Saint-Geniez et al., 2008; Kubota et al., 2011), but its details
remain ambiguous. Therefore, we examined the expression of
VEGFR2 and VEGFR1 in retinas using recently developed bacte-
rial artificial chromosome (BAC)-transgenic mice (Ishitobi et al.,
2010; Matsumoto et al., 2012). Although VEGFR1 was restricted
to endothelial cells, VEGFR2 was abundantly expressed in theneuroretina, even more strongly than in endothelial cells
including tip cells (Gerhardt et al., 2003) that lead angiogenic
outgrowth (Figures 1A–1L). VEGFR2 expression was undetected
in both astrocytes andmacrophages (Figures S1A–S1F available
online). This expression pattern was consistent with that
observed in Vegfr2+/EGFP knockin mice (Ema et al., 2006),
although fewer neuronal cells were labeled in those mice (Fig-
ures S1G–S1J). In other tissues, both VEGFR1 and VEGFR2
were expressed only in endothelial cells, except for the unex-
pected VEGFR2 expression in lung Clara cells (Figure 1M). In
this regard, Bellon et al., (2010) showed slight VEGFR2 expres-
sion in brain neurons by immunohistochemistry. It is likely that
the VEGFR2 expression in brain neurons is under the level we
could detect in VEGFR2-BAC-EGFPmice. Sectioned specimens
showed that VEGFR2 was abundant throughout the neuroretina
during the first week after birth, but gradually decreased as post-
natal (P) development continued (Figures 1N–1U). Costaining
with various markers indicated that the minor population ofCell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc. 585
VEGFR2-positive cells at P13 was Mu¨ller cells (Figures S1K–
S1N). This temporal transition of VEGFR2 expression in the neu-
roretina was similarly detected in Vegfr2+/LacZ knockin mice
(Shalaby et al., 1997) (Figures 1V–1Y) as well as in the VEGFR2
immunohistochemical analysis (Figures S1O–S1R). Next, we
explored the regulatory mechanism for the neuroretinal Vegfr2
expression that diminishes after the neonatal period.We recently
reported an enhancer of Vegfr2, the distal-multipotent-meso-
dermal-enhancer (DMME), which contains Gata-, Cdx-, Tcf/
Lef-, ER71/Etv2-, and Fox-binding sites (Ishitobi et al., 2011).
The DMME is active in hemangioblasts and cardiovascular pro-
genitors, but not in endothelial cells. In the DMME-GFP reporter
mice, the DMME was active in the neuroretina of neonates (Fig-
ures 1Z and 1AA) but not in stages after P7 (data not shown).
Taken together, these data indicate that VEGFR2 is strongly ex-
pressed in the neuroretina when the neuronal area is avascular.
Misdirected Sprouting in Neuronal Vegfr2
Knockout Mice
To determine the function of VEGFR2 in the neuroretina, we
crossed Vegfr2-flox mice with Pax6a-Cre mice (Marquardt
et al., 2001; Kurihara et al., 2010; Nakamura-Ishizu et al., 2012),
which express Cre specifically in the neuroretina, apart from
the area near the optic nerve head (Figures S2A and S2B). The
resultant conditional knockout mice (Pax6a-Cre+Vegfr2flox/flox:
Vegfr2Dneuro mice) showed ragged and caved edges in their
vascular fronts, accompanied by persistent hyaloid vessels and
a slight delay in the radial growth compared to that in control
mice (Pax6a-Cre-Vegfr2flox/flox) (Figures 2A, 2E, and 2N). A strik-
ing abnormality was observed in the 3D direction of the vascular
growth. At P6, Vegfr2Dneuro mice showed abundant vertical
branching into the neuroblastic layer, and this was absent in con-
trol mice (Figures 2A–2N and S2C–S2F). These vertical branches
in Vegfr2Dneuro mice had a normal morphology similar to that
observed in VEGF-guided sprouting vessels utilizing tip cell filo-
podia (Gerhardt et al., 2003) (Figures 2H and 2K) and different
from the pathologically aberrant invaginations observed in adult
mice with a very low density lipoprotein receptor deficiency (Dor-
rell et al., 2009). Comparable numbers of total endothelial cells
quantified using fluorescence-activated cell sorting (FACS) anal-
ysis suggested that the defect in Vegfr2Dneuromice ismisdirected
vascular growth rather thanadditional angiogenesis (FigureS2G).
In a later stage at P9, when control mice had just started to form
vertical branches, deep and intermediate plexuses were already
formed in Vegfr2Dneuro mice (Figures 2O–2T). At P28, vessel
branching in intermediate and deep plexuses was remarkably
increased in Vegfr2Dneuromice (Figure S2H-P). Deletion of Vegfr2
in endothelial cells (VEcad-CreERT2+Vegfr2flox/lox; Vegfr2iDEC)
severely impaired the radial vascular growth but did not lead
to sprouting misdirected into the neuroretina (Figures 2U–2X).
In addition, a myeloid-specific Vegfr2 deletion (Vav1-iCre+
Vegfr2flox/lox; Vegfr2Dmyeloid) using Vav1-iCre (de Boer et al.,
2003) did not affect retinal vascularization (Figures S2Q–S2V).
Normal Retinogenesis in Neuronal Vegfr2
Knockout Mice
VEGFR2 functions as a neurotrophic factor for brain neurons in
pathologies such as amyotrophic lateral sclerosis (Lambrechts586 Cell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc.et al., 2003). In addition, VEGFR2 is functional in adult retinal neu-
rons (Saint-Geniez et al., 2008; Nishijima et al., 2007). Indeed, we
detected phosphorylated VEGFR2 (pVEGFR2) proteins at P3 in
the peripheral half of retinal tissues, which largely consist of neu-
rons and completely lack vascular structure (Figure S3A).
Considering these data, we hypothesized that the vascular
phenotype in Vegfr2Dneuromice is a secondary effect in degener-
ated retinal neurons. However, to our surprise, immunohisto-
chemical analysis in the retinas of Vegfr2Dneuro mice indicated
no detectable abnormalities in neuronal thickness, morphology,
proliferation, or survival (Figures 3A–3I, 3N–3P, and S3B–S3L),
suggesting that other neurotrophic factors masked the effect
of VEGFR2 in vivo. Conversely, Vegfr2iDEC showed decreased
retinal thickness, particularly in the thickness of the inner plexi-
form layer (IPL) (Figures S3C, S3F, S3I, S3K, and S3L), likely
due to an insufficient vascular supply to the neuroretina. Trans-
mission electron microscopy revealed that the vertical sprouts
in Vegfr2Dneuro mice extended between normal ganglion cells
(Figures 3J–3M). Retinal vascularization is guided by astrocytes
(Gerhardt et al., 2003; Fruttiger et al., 1996) and ganglion cells
(Sapieha et al., 2008; Binet et al., 2013). In Vegfr2Dneuro mice,
the morphology of such guidance cells was not altered and
the vertical branching proceeded below their mesh (Figures
3Q–3V). The electroretinography showed intact visual function
of retinal neurons in Vegfr2Dneuro mice (Figures 3W and 3X). Im-
munostaining with cell-type-specific markers indicated the dif-
ferentiation into all neuronal cell types was completed in adult
Vegfr2Dneuro mice (Figure S3M).
Inadequate VEGF Endocytosis in Neuronal Vegfr2
Knockout Mice
Next, we hypothesized that the expression of angiogenic or anti-
angiogenic cytokines might be altered in Vegfr2Dneuro mice.
However, quantitative PCR analysis failed to detect a significant
difference in all of them between control and Vegfr2Dneuro mice
(Figure 4A), and some of these results were confirmed using
the analysis of their protein levels (Figure S4A). In the western
blot analysis, we found the amount of VEGF-A protein was
increased in the extracellular spaces of Vegfr2Dneuro mice (Fig-
ures 4B and 4C). VEGFR2 is actively endocytosed in endothelial
cells, especially those cells located in vascular fronts (Nakayama
et al., 2013, Lampugnani et al., 2006). Thus, this finding promp-
ted us to test whether a similar event occurs in the neuroretina.
Multiple VEGF-A-positive and early endosomal antigen 1
(EEA1)-positive spots were detected in neuroretinal cells (Fig-
ures 4D–4I). As was shown in endothelial cells, colocalization
of endocytosed VEGF and VEGFR2 was detected in retinal
neurons (Figures S4B–S4J). We also explored the fate of the
internalized VEGF-A in neurons using an in vitro assay. Alexa
546-labeled hVEGF was administered into the culture of retinal
neurons sorted using FACS (GFP+ cells from Pax6aCre+flox-
CAT-EGFP+ retinas). Endocytosis of the labeled VEGF occurred
10 min after administration, and VEGF+ endosomes were gradu-
ally decreased after removal of the labeled VEGF (Figures S4K–
S4N). These data indicate that, as in endothelial cells (Lampug-
nani et al., 2006), endocytosed VEGF proteins are immediately
degraded proteolytically and are not accumulated or recycled
in retinal neurons. VEGF-A endocytosis in Pax6a-Cre+ cells in
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Figure 2. Misdirected Sprouting in Neuronal Vegfr2 Knockout
(A–H) Whole-mount staining in retina at P6. (C, D, G, and H) 3D images from multiple z stack scanning slices of the ganglion cell layer (GCL) to the neuroblastic
layer (NBL). Caved edges and vertical branches (open arrowheads) with tip cell filopodia (closed arrowheads) as well as persisting hyaloid vessels (arrows) are
observed in Vegfr2Dneuro but not in control mice.
(I) Scheme depicting misdirected angiogenesis in Vegfr2Dneuro mice.
(J–M) Immunostaining of whole-mount retinas (J and K) or thick sections (60 mm) (L and M) at P6. Vertical branches in Vegfr2Dneuro mice growing into the
neuroretina (open arrowheads).
(N) Quantification at P6 (n = 5).
(O) Scheme depicting three vascular plexuses in adult retinas.
(P–T) Whole-mount staining and quantification of retina at P6. The gap between the vascular front of superficial and deep plexuses (S–D gap: dotted line in P, Q)
measured midline between arteries (A) and veins (V).
(U–X) Whole-mount staining of retina at P6. Vegfr2iDEC indicates the retina of VEcad-CreERT2 +Vegfr2flox/loxmice treated with 4-hydroxytamoxifen (4OHT) for three
days. Scale bars represent 500 mm (A, E, P, Q, U, and V); 50 mm (B–D, F–H, J–M, R, S,W, and X); **p < 0.01; ND, not detected. Data are represented asmean ±SD.
See also Figure S2.Vegfr2Dneuro mice was almost undetectable (Figures 4J–4L). All
of these data suggested that an excessive amount of VEGF-A
protein in the neuroretinal layer caused preterm vertical growth
of blood vessels. Previously, we reported that mice with a
Pax6a-Cre-mediated Vhl deletion (VhlDneuromice) show a persis-
tence of hyaloid vessels through insufficient suppression of the
HIF1a/VEGF-A pathway (Kurihara et al., 2010). When we exam-
ined the retina of VhlDneuro mice with VEGF-A expression levels
more than four times higher than those of wild-type mice, wefound that VhlDneuro mice exhibited early vertical branching
from primary vascular plexuses (Figures 4M–4R). Normalization
of VEGF-A levels by concomitant deletion of Hif1a abolished
this misdirected branching (Figures 4S–4U).
Deletion of VEGF in Neurons Normalizes Neuronal
Vegfr2 Knockout Mice
Based on the data above, we hypothesized that neuronal
VEGFR2 spatiotemporally regulates the amount of VEGF-ACell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc. 587
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Figure 3. Normal Retinogenesis in Neuronal Vegfr2 Knockout
(A–F) Section staining of retinas at P5 (A and B) or P6 (C–F). Physiological apoptosis in the inner nuclear layer and proliferation in the most peripheral area are
similarly detected in both control and Vegfr2Dneuro mice.
(G and H) Quantification at P6 (n = 4).
(I) Retinal thickness quantified at various distances from the optic disk (OD) at P9 or P28.
(J–M) Transmission electron microscopy of retina at P6. Vertical sprouting (arrowheads) between normal ganglion cell bodies (asterisks).
(N and O) Staining of retinal sections at P6. Arrows indicate retinal ganglion cells.
(P) Quantification of double-labeled NeuN+Thy1.1+ ganglion cells at P6 (n = 5).
(Q–V) Whole-mount staining of retina at P6. Vertical sprouts in Vegfr2Dneuro mice are projected below the mesh of astrocytes and neurofilaments (open
arrowheads).
(W and X) Electroretinography at P28. Representative wave responses (W) and amplitude quantification of a-waves and b-waves (X) (n = 4). Scale bars represent
500 mm (A–F); 50 mm (Q–V); 10 mm (J–O); NS, not significant. Data are represented as mean ± SD.
See also Figure S3.protein near neurons and consequently orchestrates the timing
of vertical branching into deep retinal layers. To test this hypoth-
esis, we pharmacologically decreased the amount of VEGF-A
with intraocular injections of Flt1/Fc chimeric proteins that bind
and inactivate VEGF proteins (Kurihara et al., 2010). Although in-
jections of more than 500 ng of Flt1/Fc proteins impaired the
radial growth of superficial plexuses (data not shown), injections
of 50 ng did not significantly affect the superficial plexus but
normalized the vertical branching in Vegfr2Dneuro mice (Figures
5A–5I and 5V). We confirmed this finding genetically by gener-
ating mice with Pax6a-Cre-mediated simultaneous deletions of
Vegfa and Vegfr2 because VEGF-A is expressed in retinal neu-588 Cell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc.rons as well as astrocytes (Figures S5A and S5B) in accordance
with a previous report (Saint-Geniez et al., 2008). Double
knockout mice (Pax6a-Cre+Vegfr2flox/floxVegfaflox/flox) did not
show the early vertical branching observed in Vegfr2Dneuro
mice (Figures 5J–5U and 5W). Consistent with the data gener-
ated in the Nestin-Cre-mediated Vegfa deletion (Haigh et al.,
2003), the Pax6a-Cre-mediated Vegfa deletion did not disturb
the overall vascular architecture of superficial vascular plexuses,
except for some arteriovenous crossings (Figure 5O), as was
also seen in double knockout mice (Figure 5Q). We performed
VEGF immunohistochemistry on retinal sections of mutant
mice to determine the spatial distribution of VEGF. Consistent
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Figure 4. Insufficient VEGF Endocytosis in Neuronal Vegfr2 Knockout
(A) Quantitative PCR analysis of angiogenic factors in retinal tissues at P6 (n = 4).
(B and C) Western blot analysis and quantification of relative intensity (n = 3) for supernatant and cellular components separated by enzymatic dissociation and
centrifugation.
(D–L) Whole-mount staining and quantification for P6 retinas (10 fields (50 mm3 50 mm) averaged in each of three individuals). VEGF-A-positive spots detected in
the cytoplasm of retinal neurons (asterisks). Some EEA1-positive early endosomes contain VEGF-A (closed arrowheads) but others do not (open arrowheads).
Insets in (J) and (K) show only green channels in the grid areas.
(M–U) Whole-mount staining for P6 retinas. Not only persisting hyaloid vessels (asterisks) but also early vertical branches (arrowheads) are detected in VhlDneuro
but not in control and Vhl; Hif1aDneuromice. Scale bars represent 500 mm (M, P, and S); 50 mm (N, O, Q, R, T, and U); 5 mm (D–K); *p < 0.05; NS, not significant; ND,
not detected. Data are represented as mean ± SD.
See also Figure S4.with the idea of local VEGF sequestering by VEGFR2-positive
neurons, VEGF immunoreactivity was strongly detected in the
neuroretina of Vegfr2Dneuro and VhlDneuro and was normalized
or rather decreased in Vhl;Hif1aDneuro and Vegfr2; VegfaDneuro
(Figures S5C–S5J).
Endocytosis Deficiency Recapitulates Defects in
Neuronal Vegfr2 Knockout Mice
The above data indicated that misdirected angiogenesis
was caused by excessive VEGF protein around the neurons of
Vegfr2Dneuro mice, which was likely due to insufficient endocy-
tosis of VEGF. However, another possible explanation is the
lack of soluble Vegfr2 (sVegfr2), a splice variant of the gene
encoding Vegfr2 that encodes a secreted form of the protein (Al-
buquerque et al., 2009). Theoretically, the lack of the VEGFsequestering ability by sVegfr2 could increase free VEGF pro-
teins, resulting in premature vascular invasion, as seen in
Vegfr2Dneuro mice. In an RT-PCR analysis of various tissues,
we found that sVegfr2 expression was relatively abundant in
retinal tissues (Figures S6A and S6B). To functionally evaluate
sVegfr2 in the retina, we generated mice lacking sVegr2 but
not membrane bound Vegfr2 (mbVegfr2) by deleting intron13,
which is responsible for this splice variant (Figures 6A and 6B).
Analysis of the neonatal skin clearly indicate lymphatic vessels
are apparently enlarged and hyperplastic in mice with the sys-
temic deletion of sVegfr2 (Vegfr2Ds/Ds) (Figures S6C and S6D)
in agreement with a previous paper (Albuquerque et al., 2009).
However, Vegfr2Ds/Ds and mice with the neuron-specific deletion
of sVegr2 (Pax6a-Cre+Vegfr2flox/Ds: sVegfr2Dneuro) showed no
misdirected retinal angiogenesis (Figures 6C–6K). RegardingCell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc. 589
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Figure 5. Reduction of VEGF-A Normalizes Neuronal Vegfr2 Knockout
(A–U) Whole-mount staining of retina at P6 and quantification (n = 4). Vertical branches (arrowheads) seen in Vegfr2Dneuro mice are abolished by intraocular
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See also Figure S5.the lack of retinal phenotypes in Vegfr2Ds/Ds and sVegfr2Dneuro, a
likely explanation is that the amount of sVegfr2 is very low, and
thus its VEGF sequestering effect is negligible in retinal neurons.
To clarify the involvement of endocytosis in retinal neurons, we
conditionally deleted Dynamin1 and Dynamin2, genes known
to critically and cooperatively act on cellular endocytosis (Fergu-
son et al., 2009). In the retina of the resultant mutant mice
(Pax6a-Cre+Dnm1flox/floxDnm2flox/flox: Dnm1;Dnm2Dneuro), early
vertical sprouting occurred as expected, although the superficial
plexus in these mice was more severely impaired than that in
Vegfr2Dneuro mice (Figures 6L–6Q). The morphology of the neu-
roretina was largely normal, but we detected insufficient se-
paration of the inner nuclear layer (INL) and the outer nuclear
layer (ONL) and reduced numbers of Pax6-positive cells in
Dnm1;Dnm2Dneuro mice (Figures S6E–S6J). In this regard, the
phenotype in Dnm1;Dnm2Dneuro mice might be attributable to
angiogenic factors other than VEGF, such as Netrin1, Sema3A,
and Sema3E, which are known to be expressed in retinal neu-
rons and are involved in angiogenesis. To rule out this possibility,
we performed a combinatorial deletion of VEGF on Dnm1 and
Dnm2 knockouts, generating triple conditional knockout mice
for these three genes in retinal neurons (Pax6aCre+Dnm1flox/flox
Dnm2flox/floxVegfaflox/flox; Dnm1;Dnm2;VegfaDneuro). We found
that this mutant mouse showed no misdirected angiogenesis,590 Cell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc.although the vascular defects in the superficial plexus remained
similar to those in Dnm1;Dnm2Dneuro mice (Figures 6N, 6Q, 6T,
and 6U). In agreement with this result, the ratio of free to cellular
VEGF proteins was increased inDnm1;Dnm2Dneuromice, with no
change in the transcription level (Figures 6V and 6W), as was
observed in Vegfr2Dneuro mice. These data indicate that other
angiogenic factors or neuronal defectsmay be relevant to abnor-
malities in superficial plexuses, but premature vessel invasion is
attributable to VEGF.
Misdirected Regenerative Angiogenesis in Neuronal
Vegfr2 Knockouts in Retinal Pathology
Finally, we explored the effect of neuronal Vegfr2 deletion in
pathological and regenerative angiogenesis in the ischemic reti-
nopathy (Smith et al., 1994). Although the extent of pathological
angiogenesis was not altered, regenerative angiogenesis into the
vaso-obliterated area was decreased in Vegfr2Dneuro mice (Fig-
ures 7A–7H). Looking closer at the leading edge, we found that
Vegfr2Dneuro mice showed abnormal vessels growing into intra-
capillary spaces (Figure 7D), likely the cause of delayed vascular
regeneration. The reparative angiogenesis did not progress to
the deep layer in either control or Vegfr2Dneuro mice (Figures 7E
and 7F). VEGFR2-positive neurons were markedly multilayered
in the intracapillary spaces of the ganglion cell layer rather than
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See also Figure S6.in the deep layer (Figures 7I–7K). This feature was not observed
in the normal physiological development occurring around this
stage (Figures 1T and 1X). All of these expression data indi-
cate that neuronal control of the amount of VEGF proteins in
this disease model primarily functions in the horizontal retinal
layer. The vaso-obliterated area immediately after hyperoxygen
exposure showed no significant difference between control
and Vegfr2Dneuro mice (Figures 7L–7N).
DISCUSSION
In the developing retina, angiogenic growth led by VEGFR2+
endothelial tip and stalk cells proceeds according to the gradientof VEGF mainly secreted by astrocytes (Gerhardt et al., 2003;
Potente et al., 2011). Our results demonstrated that retinal neu-
rons also highly expressed VEGFR2, thus binding and engulfing
VEGF proteins around neurons. In neuron-specific deletions of
Vegfr2, free VEGF proteins are markedly increased due to neu-
rons insufficiently engulfing VEGF, which resulted in misdirected
angiogenic growth toward neurons (Figure 7O).
Cell-autonomous VEGF signaling in endothelial cells is
required for vascular homeostasis (Lee et al., 2007). In endothe-
lial cells, intracrine VEGF binds internalized VEGFR2, and all the
ligand-receptor actions take place in the cytoplasm. The auto-
crine systems in the endothelium and neurons may differ slightly.
Based on our data, it is likely that the VEGF produced by retinalCell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc. 591
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Stefater et al. (2011) recently reported that the loss of the Wnt/
Vegfr1 signaling in myeloid cells leads to an overgrowth of deep
vascular plexus but not to early vertical sprouting. It is supposed
that neurons and myeloid cells serially and cooperatively re-
gulate the formation of the deep vascular plexus. Interesting
vascular phenotypes are observed in mice lacking Norrin, which
activates the canonical Wnt signaling via the endothelial Friz-
zled4/LRP5 pathway. Norrin null mice show aberrant prolifera-
tion in vertical branches, which fail to extend to the inner nuclear
layer, likely due to an enhanced response to antiangiogenic fac-592 Cell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc.tors, such as class 3 semaphorins (Ye et al., 2009; Wang et al.,
2012). Cooperation between VEGF/VEGFR2 and the Norrin/
Wnt signaling may balance the timing and amount of vertical
branching. One question is why the vertical vascular growth in
Vegfr2Dneuro mice stopped in the inner nuclear layer and did
not grow into the outer nuclear layer. This may be explained by
soluble VEGFR1 that binds VEGF proteins in photoreceptor
layers (Luo et al., 2013).
During the first postnatal week, neuroretinal cells remain undif-
ferentiated as retinal progenitor cells and postmitotic progenitors
(Marquardt et al., 2001).We showed that DMME is active in these
cells. Because DMME contains Gata-, Cdx-, Tcf/Lef-, ER71/
Etv2-, and Fox-binding sites, neuroretinal Vegfr2 expression is
likely under the control of the Wnt, Fgf, and Bmp families known
to control the undifferentiated status of retinal progenitor cells
(Lillien and Cepko, 1992; Kubo et al., 2005). A low oxygen envi-
ronment, called a hypoxic niche, is suitable for maintaining stem
cells (Mohyeldin et al., 2010), suggesting the compelling hypoth-
esis that stem cell factors simultaneously contribute to creating a
hypoxic niche via neuronal VEGFR2 expression as a tissue-spe-
cific mechanism.
One of the important issues we could not uncover is the bio-
logical significance of such a spill-over production of VEGF by
neurons.We speculate that neuronal VEGF contributes tomainte-
nance of hyaloid vessels (Lang, 1997), a part of the fetal-type cir-
culatory system in retina. In embryonic retinas and the peripheral
part of neonatal retinas, astrocytes are totally absent and neurons
are the only source of VEGF. For maintenance of hyaloid vessels,
neurons once excessively secrete VEGF proteins and then engulf
them around neurons themselves. Supporting this idea, we previ-
ously showed that the overproduction of VEGF in neurons leads to
persistence of hyaloid vessels (Kurihara et al., 2010). Moreover,
our preliminary data using Dkk3-BAC-Cre, another retinal
neuron-specific Cre line, indicate the complete deletion of VEGF
in neurons ablates hyaloid vessels (data not shown).
Finally, the results of the present study revealed neurovascular
crosstalk that explains how the retinal vascularization primarily
radiates 2D along the GCL while the neuroretinal area remains
avascular. Further analysis is expected to offer novel insights
into the pathology of human retinal neovascular diseases, such
as age-related macular degeneration and diabetic retinopathy,
in which retinal neurovascular crosstalk is expected to be highly
relevant.
EXPERIMENTAL PROCEDURES
Mice and Analysis
Animal care was performed in accordance with the Guidelines of Keio
University for Animal and Recombinant DNA experiments. Pax6a-Cre mice
(Marquardt et al., 2001) were a gift from Peter Gruss (Max-Planck-Institute
of Biophysical Chemistry). Vegfr2Ds/Ds knockin mice and transgenic mice ex-
pressing CreERT2 under the control of the 200.3 kb VE-cadherin promoter
sequence obtained from a BAC clone (RP23-453P1) were newly generated.
The 4-hydroxytamoxifen (40 mg) was subcutaneously injected at P3, P4, and
P5. Vegfa-flox mice (Gerber et al., 1999) were kindly provided by Genentech.
Vhl-flox (Haase et al., 2001) and Hif1a-flox mice (Ryan et al., 2000) were gifts
from Rudolf Jaenisch (The Whitehead Institute for Biomedical Research) and
Randall Johnson (University of Cambridge), respectively. Pax6a-Cre mice
were mated with Vegfr2-flox mice (Hooper et al., 2009) to obtain neuron-spe-
cific Vegfr2 knockout mice. Vav1-iCre, Dnm1-flox and Dnm2-flox mice were
obtained from the Jackson Laboratory. Heterozygous pups of Vegfr2+/lacZ
(Shalaby et al., 1997), Vegfr1-BAC-DsRed, Vegfr2-BAC-EGFP, and Vegfr2-
DMME-EGFP (Ishitobi et al., 2011) mice were used. All mice were maintained
on a C57BL/6J background.
Preparation of Whole-Mount Retinas
Enucleated eyes were fixed for 20 min in 4% paraformaldehyde (PFA) in PBS
and then dissected. Retinal cups were postfixed for 30min and then stained as
described below.
Preparation of Retinal Sections
Enucleated eyeswere fixed for 10min in 4%PFA in PBS and then hemispheres
were cut. After overnight postfixation, samples were snap-frozen in OCT com-
pound (Sakura Finetechnical). All specimens were sectioned (10–60 mm thick)
at the plane of the optic disk.Retinal Immunostaining and In Situ Hybridization
Immunohistochemistry (IHC) of whole-mount samples or tissue sections was
performed as previously described (Kubota et al., 2011). For the BrdU incorpo-
ration assay, 100 mg of BrdU per gram of body weight (BD PharMingen)
dissolved in sterile PBSwas injected intraperitoneally 2 hr before sacrifice. Iso-
lated retinas were stained using a BrdU immunohistochemistry kit (Calbio-
chem). The primary monoclonal antibodies used were hamster anti-CD31
(2H8; Chemicon), PDGFRa (APA5; eBioscience), neurofilament (2H3; Develop-
mental Studies Hybridoma Bank), Pax-6 (Developmental Studies Hybridoma
Bank), glutamine synthetase (BD Biosciences), F4/80 (CI:A3-1; Serotech),
GFAP (G-A-5; Cy3-conjugated; Sigma-Aldrich), Thy1.1 (Chemicon), Calbindin
(Chemicon), PKCa (BD Transduction Laboratories), VEGFR2 (BD PharMin-
gen), and syntaxin (SP7; Millipore). The primary polyclonal antibodies used
were anti-GFP (Alexa488-conjugated; Molecular Probes), rhodopsin (LSL),
sox9 (Millipore), VEGF (Santa Cruz), LYVE-1 (RELIATech), NeuN (Abcam),
and EEA1 (Sigma-Aldrich). Secondary antibodies usedwere Alexa 488 fluores-
cence-conjugated IgGs (Molecular Probes) or Cy3/Cy5 DyLight549/Dye-
Light649-conjugated IgGs (Jackson ImmunoResearch). For nuclear staining,
specimens were treated with DAPI (Molecular Probes). In some experiments,
blood vessels and monocyte-lineage cells were simultaneously visualized
using biotinylated isolectin B4 (Sigma) followed by fluorescent streptavidin
conjugates (Molecular Probes). For in situ hybridization, retinas were briefly
digested with proteinase K and hybridized with digoxigenin (DIG)-labeled
antisense RNA probes, as described previously (Kubota et al., 2011). ImageJ
software equipped with the colocalization plugin Coloc2 (NIH) was used to
quantify colocalization events.
X-Gal Staining of Tissue Sections
Enucleated eyes were fixed for 10 min in 1% glutaraldehyde in PBS and then
hemispheres were cut. After overnight postfixation, samples were snap-frozen
in OCT compound (Sakura Finetechnical). Specimens were sectioned (10 mm
thick) at the plane of the optic disk. Tissue sections were incubated for 1 hr at
37C with 1 mg/ml of X-gal in a standard X-gal reaction buffer (35 mM potas-
sium ferrocyanide, 35mMpotassium ferricyanide, 2mMMgCl2, 0.02%NP-40,
and 0.01% sodium deoxycholate in PBS).
Confocal Microscopy
Fluorescent images were obtained using a confocal laser scanning micro-
scope (FV1000; Olympus). Quantification of cells or substances of interest
was conducted on eight 500 mm3 500 mmfields of view per sample in scanned
images, and numbers obtained from each of the eight fields were averaged. To
construct 3D images, multiple slices horizontally imaged from the same field
of view at 0.5 mm intervals were integrated using an FV10-ASW Viewer
(Olympus).
Intraocular Injections
Injections into the vitreous body were performed using 33 gauge needles as
described previously (Kubota et al., 2011). Sterile PBS (0.5 ml) with or without
0.1 mg/ml of Flt1-Fc chimera proteins (R&D Systems) was injected at P4.
Ischemic Retinopathy Model
P8 mice with nursing mothers were maintained for 3 days in 85% oxygen and
then placed back in room air in a modification of the previously described ox-
ygen-induced retinopathy (OIR) model (Smith et al., 1994). ImageJ Software
was used for the quantification of indicated areas in scanned images as previ-
ously described (Kubota et al., 2011).
Western Blotting
Western blot analysis was performed as described elsewhere (Kubota et al.,
2011). The primary antibodies used were anti-VEGF (Santa Cruz), phosphory-
lated-VEGFR2 (Millipore), VEGFR2 (Cell Signaling), VEGF-C (RELIATech), An-
giopoietin-1 (Santa Cruz), Angiopoietin-2 (Abcam), HIF1a (Santa Cruz), HIF2a
(Abcam), and HSC70 (Santa Cruz). ImageJ software was used to measure the
density of each band. For separation of extracellular and cellular components,
retinal tissues were incubated for 30 min at 37C in Dulbecco’s minimum
essential medium (DMEM) containing 1% collagenase D (from Clostridium
histolyticum) before cells were dissociated by gentle trituration. AfterCell 159, 584–596, October 23, 2014 ª2014 Elsevier Inc. 593
300 rpm centrifugation for 10 min, the supernatant and cellular components
were separated.
Transmission Electron Microscopy
Retinal samples were fixed with 2.5% glutaraldehyde and subjected to
examination by transmission electron microscopy (TEM). Sections (1 mm thick)
were stained with methylene blue and thin-sectioned with a diamond knife.
The sections were collected on mesh grids, stained with uranyl acetate and
lead citrate, and examined under an electron microscope (1230 EXII; JOEL).
Quantitative RT-PCR Analysis
Total RNA was prepared from retinal tissues and reverse transcription was
performed using Superscript II (Invitrogen). Quantitative PCR assays were per-
formed with an ABI 7500 Fast Real-Time PCR System using TaqMan Fast Uni-
versal PCR master mix (Applied Biosystems) and TaqMan Gene Expression
assay mix of vegfa (Mm00437304_ml), vegfc (Mm01202432_ml), vegfr2
(Mm00440099_ml), vegfr1 (Mm00438780_ml), angpt1 (Mm00456503_ml),
angpt2 (Mm00545822_ml), tek (Mm00443242_ml), dll4 (Mm00444619_m1),
notch1 (Mm00435259_ml), cxcl12 (Mm00445552_ml), cxcr4 (Mm01292123_
ml), hif1a (Mm00468878_ml), and tgfb1 (Mm00441724_m1). A mouse b-actin
(Mm00607939_s1) assay mix served as an endogenous control. Data were
analyzed using 7500 Fast System SDS software 1.3.1. Each experiment was
performed with four replicates from each sample, and the results were
averaged.
Cell Culture
Retinal cell culture was performed according to a previous report (Kubota
et al., 2011). Briefly, retinal tissues were incubated for 30 min at 37C in
DMEM containing 1% collagenase D (from Clostridium histolyticum) before
cells were dissociated by gentle trituration. A flow cytometer, SORP
FACSAria (BD) with FlowJo software (TreeStar) was used to analyze stained
samples. GFP+ cells were sorted from the P1 retinas of Pax6a-Cre+flox-
CAT-EGFP+ mice using fluorescence-activated cell sorting (FACS). Cells
were washed and resuspended in DMEM containing 10% fetal bovine serum
and then plated on poly-D-lysine-coated culture slides. The samples were
incubated at 37C in 20% O2. Cells were supplemented with recombinant
hVEGF165 proteins (Peprotech) labeled with Alexa Fluor 546 using a labeling
kit (Molecular Probes) according to the manufacturers’ instruction and a pre-
vious paper (Nakayama et al., 2013). Ten minutes after incubation with
Alexa546-labeled hVEGF, the culture medium was replaced with medium
free from Alexa546-labeled hVEGF.
Electroretinography
Electroretinography was performed as previously described (Kurihara et al.,
2010). The responses were differentially amplified and filtered through a digital
bandpass filter ranging from 0.313 to 1000 Hz to yield a- and b-waves. Light
pulses of 800 cd 3 s/m2 and 4 ms duration were delivered via a commercial
Ganzfeld stimulator (Ganzfeld System SG-2002; LKC Technologies). The
amplitude of the a-wave was measured from the baseline to the trough of
the a-wave, and the amplitude of the b-wave was determined from the trough
of the a-wave to the peak of the b-wave. The implicit time of the a- and
b-waves was measured from the onset of stimuli to the peak of each wave.
Statistical Analysis
Results are expressed as the mean ± SD. The comparisons between the aver-
ages of the two groups were evaluated using the two-tailed Student’s t test.
The p values < 0.05 were considered statistically significant.
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